nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Animal models for the study of HBV replication and its variants
|
Dandri, M. |
|
2005 |
34 |
S1 |
p. S54-S62 9 p. |
artikel |
2 |
Clinical impact of occult HBV infections
|
Chemin, I. |
|
2005 |
34 |
S1 |
p. S15-S21 7 p. |
artikel |
3 |
Detection of hepatitis B virus genotypes and mutants: current status
|
Niesters, Hubert G.M. |
|
2005 |
34 |
S1 |
p. S4-S8 5 p. |
artikel |
4 |
DNA-designed avian IgY antibodies: novel tools for research, diagnostics and therapy
|
Cova, Lucyna |
|
2005 |
34 |
S1 |
p. S70-S74 5 p. |
artikel |
5 |
HBV epidemiology in Latin America
|
Paraná, Raymundo |
|
2005 |
34 |
S1 |
p. S130-S133 4 p. |
artikel |
6 |
HBV induced carcinogenesis
|
Cougot, Delphine |
|
2005 |
34 |
S1 |
p. S75-S78 4 p. |
artikel |
7 |
Hepatitis B virus genome variability and disease progression: the impact of pre-core mutants and HBV genotypes
|
Buti, Maria |
|
2005 |
34 |
S1 |
p. S79-S82 4 p. |
artikel |
8 |
Identification of hepatitis B virus genome in faecal sample from wild living chimpanzee (Pan troglodytes troglodytes) in Gabon
|
Makuwa, M. |
|
2005 |
34 |
S1 |
p. S83-S88 6 p. |
artikel |
9 |
Immune system and hepatitis B virus infection
|
Hui, Chee-Kin |
|
2005 |
34 |
S1 |
p. S44-S48 5 p. |
artikel |
10 |
Mechanism of HBV genome variability and replication of HBV mutants
|
Tong, Shuping |
|
2005 |
34 |
S1 |
p. S134-S138 5 p. |
artikel |
11 |
Molecular epidemiology of chronic hepatitis B virus infection in northern Poland
|
Bielawski, Krzysztof Piotr |
|
2005 |
34 |
S1 |
p. S63-S69 7 p. |
artikel |
12 |
Molecular epidemiology of hepatitis B in England and Wales
|
Teo, C.G. |
|
2005 |
34 |
S1 |
p. S13-S14 2 p. |
artikel |
13 |
New targets and inhibitors of HBV replication to combat drug resistance
|
Cheng, Yung-Chi |
|
2005 |
34 |
S1 |
p. S147-S150 4 p. |
artikel |
14 |
Phenotyping hepatitis B virus variants: From transfection towards a small animal in vivo infection model
|
Nassal, Michael |
|
2005 |
34 |
S1 |
p. S89-S95 7 p. |
artikel |
15 |
Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing
|
Durantel, David |
|
2005 |
34 |
S1 |
p. S34-S43 10 p. |
artikel |
16 |
Software and expert system for the management of chronic hepatitis B
|
Neirotti, Riccardo |
|
2005 |
34 |
S1 |
p. S29-S33 5 p. |
artikel |
17 |
The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: Theoretical considerations
|
Litwin, Samuel |
|
2005 |
34 |
S1 |
p. S96-S107 12 p. |
artikel |
18 |
The concept of hepatitis B virus mutant escape
|
Pawlotsky, Jean-Michel |
|
2005 |
34 |
S1 |
p. S125-S129 5 p. |
artikel |
19 |
The current management of HBV drug resistance
|
Liaw, Yun-Fan |
|
2005 |
34 |
S1 |
p. S143-S146 4 p. |
artikel |
20 |
The current status of antiviral therapy of chronic hepatitis B
|
Asselah, Tarik |
|
2005 |
34 |
S1 |
p. S115-S124 10 p. |
artikel |
21 |
The DNA-Chip technology as a new molecular tool for the detection of HBV mutants
|
Vernet, Guy |
|
2005 |
34 |
S1 |
p. S49-S53 5 p. |
artikel |
22 |
The natural history of chronic hepatitis B virus infection
|
Villeneuve, Jean-Pierre |
|
2005 |
34 |
S1 |
p. S139-S142 4 p. |
artikel |
23 |
Therapeutic vaccination against chronic hepatitis B virus infection
|
Michel, Marie Louise |
|
2005 |
34 |
S1 |
p. S108-S114 7 p. |
artikel |
24 |
Therapeutic vaccination for chronic infectious diseases: Lessons from HIV-1
|
Verrier, B. |
|
2005 |
34 |
S1 |
p. S9-S12 4 p. |
artikel |
25 |
The use of the OraSure® collection device for hepatitis virus testing in health care settings
|
Cameron, Sheila O. |
|
2005 |
34 |
S1 |
p. S22-S28 7 p. |
artikel |
26 |
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
|
Lavanchy, D. |
|
2005 |
34 |
S1 |
p. S1-S3 3 p. |
artikel |